oleic acid has been researched along with gemcitabine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calvagno, MG; Castelli, F; Celia, C; Cosco, D; Doldo, P; Frest, M; Iannone, M; Paolino, D | 1 |
Chen, X; Cui, SH; Ding, JS; Qian, HG; Qiu, C; Sun, J; Wang, CH; Wang, H; Wang, JC; Yan, Y; Zhang, HT; Zhang, Q | 1 |
2 other study(ies) available for oleic acid and gemcitabine
Article | Year |
---|---|
Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Caco-2 Cells; Cell Survival; Cholesterol; Colloids; Deoxycytidine; Gemcitabine; Humans; Hydrogen-Ion Concentration; Lipids; Liposomes; Oleic Acid; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Prodrugs; Static Electricity; Technology, Pharmaceutical | 2007 |
Encapsulated microRNA by gemcitabine prodrug for cancer treatment.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Deoxycytidine; Drug Delivery Systems; Gemcitabine; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Nanoparticles; Oleic Acid; Particle Size; Prodrugs; Xenograft Model Antitumor Assays | 2019 |